• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

TPLC - Total Product Life Cycle

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search show TPLC since Back to Search Results
Device hydrogel spacer
Regulation Description Absorbable perirectal spacer.
Definition The perirectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the perirectal spacer to reduce the radiation dose delivered to the anterior rectum. The perirectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient’s body over time.
Product CodeOVB
Regulation Number 892.5725
Device Class 2


Premarket Reviews
ManufacturerDecision
BIOPROTECT, LTD.
  SUBSTANTIALLY EQUIVALENT 1
BOSTON SCIENTIFIC CORPORATION
  SUBSTANTIALLY EQUIVALENT 1
PALETTE LIFE SCIENCES
  SUBSTANTIALLY EQUIVALENT 1

MDR Year MDR Reports MDR Events
2021 272 272
2022 387 387
2023 327 327
2024 329 329
2025 340 340
2026 120 120

Device Problems MDRs with this Device Problem Events in those MDRs
Positioning Problem 1171 1171
Adverse Event Without Identified Device or Use Problem 358 358
Malposition of Device 130 130
Migration 56 56
Material Integrity Problem 55 55
Obstruction of Flow 34 34
Defective Device 29 29
Device Contamination with Chemical or Other Material 22 22
Inadequacy of Device Shape and/or Size 16 16
Use of Device Problem 15 15
No Apparent Adverse Event 15 15
Patient Device Interaction Problem 9 9
Material Deformation 9 9
Appropriate Term/Code Not Available 6 6
Activation, Positioning or Separation Problem 4 4
Contamination 4 4
Unsealed Device Packaging 3 3
Device Ingredient or Reagent Problem 2 2
Device-Device Incompatibility 2 2
Break 2 2
Deflation Problem 2 2
Positioning Failure 2 2
Infusion or Flow Problem 2 2
Device Dislodged or Dislocated 2 2
Connection Problem 2 2
Loose or Intermittent Connection 2 2
Fluid/Blood Leak 2 2
Leak/Splash 1 1
Device Contaminated During Manufacture or Shipping 1 1
Off-Label Use 1 1
Insufficient Information 1 1
Precipitate in Device or Device Ingredient 1 1
Difficult or Delayed Positioning 1 1
Packaging Problem 1 1
Poor Visibility 1 1
Product Quality Problem 1 1
Nonstandard Device 1 1

Patient Problems MDRs with this Patient Problem Events in those MDRs
No Clinical Signs, Symptoms or Conditions 895 895
Pain 339 339
Discomfort 199 199
Abscess 160 160
Inflammation 141 141
Fistula 138 138
Hemorrhage/Bleeding 133 133
Ulcer 122 122
Fluid Discharge 118 118
Unspecified Infection 108 108
Urinary Retention 96 96
Constipation 84 84
Fever 71 71
Perforation 60 60
Insufficient Information 52 52
Swelling/ Edema 50 50
Diarrhea 38 38
Hypersensitivity/Allergic reaction 38 38
Dysuria 30 30
Urinary Frequency 28 28
Cramp(s) /Muscle Spasm(s) 23 23
Necrosis 23 23
Unspecified Kidney or Urinary Problem 21 21
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available 17 17
Micturition Urgency 17 17
Embolism/Embolus 17 17
Hematoma 17 17
Chills 16 16
Erosion 16 16
Loss of consciousness 16 16
Syncope/Fainting 16 16
Urinary Tract Infection 16 16
Hematuria 15 15
Purulent Discharge 15 15
Nausea 14 14
Low Blood Pressure/ Hypotension 14 14
Rash 14 14
Obstruction/Occlusion 13 13
Burning Sensation 13 13
Abdominal Pain 13 13
Skin Inflammation/ Irritation 12 12
Fecal Incontinence 12 12
Bacterial Infection 12 12
Vomiting 12 12
Unspecified Tissue Injury 11 11
Sepsis 11 11
Cardiac Arrest 11 11
Urinary Incontinence 10 10
Dizziness 9 9
Itching Sensation 9 9

Recalls
Manufacturer Recall Class Date Posted
1 Boston Scientific Corporation II Apr-25-2022
-
-